Esser S, Brunetta J, Inciarte A, Levy I, et al. Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world insights from BICSTaR cohorts. HIV Med 2023 Dec 26. doi: 10.1111/hiv.13593.
PMID: 38148567